Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.89 |
| ▸ | MAPT | P10636 | 3/20 | 0.89 |
| ▸ | LMNA | P02545 | 2/20 | 0.89 |
| ▸ | TSHR | P16473 | 2/20 | 0.89 |
| ▸ | BLM | P54132 | 2/20 | 0.89 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.89 |
| ▸ | MEN1 | O00255 | 2/20 | 0.89 |
| ▸ | MPO | P05164 | 1/20 | 0.89 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | APAF1 | O14727 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 3/20 | 0.61 |
| ▸ | HTR1A | P08908 | 2/20 | 0.61 |
| ▸ | HTR2C | P28335 | 2/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.61 |
| ▸ | HTR7 | P34969 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tryptophan SCHEMBL3225377 | 1.00 | KMT2A (0.89) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL27533141 | 1.00 | KMT2A (0.89) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL27147332 | 1.00 | KMT2A (0.89) | KMT2AKDM4EMAPTLMNATSHR | |
| Tryptophan SCHEMBL7103661 | 0.95 | KDM4E (0.80) | KMT2AKDM4EMAPTLMNATSHR | |
| Tryptophan SCHEMBL23141133 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL4732052 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTLMNATSHR | |
| Tryptophan SCHEMBL475350 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL7327 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL475349 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTLMNATSHR | |
| Dl-Tryptophan SCHEMBL19161120 | 0.94 | KMT2A (1.00) | KMT2AKDM4EMAPTLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4073687-A | PENICILLINS OR CEPHALOSPORINS | SHIONOGI & CO., LTD. (JA) | 1978-02-14 | — | — | US | claimed |
| EP-4149493-A1 | METHOD OF TREATMENT OF CANCER OR TUMOUR | Adaptimmune Limited (GB) | 2023-03-22 | — | — | EP | disclosed |
| EP-4149492-A1 | MODIFIED IPSCS | Adaptimmune Limited (GB) | 2023-03-22 | — | — | EP | disclosed |
| EP-4149631-A1 | METHOD OF TREATMENT OF CANCER OR TUMOUR | Adaptimmune Limited (GB) | 2023-03-22 | — | — | EP | disclosed |
| CN-115233470-A | Preparation method of anti-mite silk fabric based on bergamot pigment | 达利(中国)有限公司 | 2022-10-25 | — | — | CN | disclosed |
| WO-2021229235-A1 | METHOD OF TREATMENT OF CANCER OR TUMOUR | ADAPTIMMUNE LIMITED (GB) | 2021-11-18 | — | — | WO | disclosed |
| WO-2021229234-A1 | METHOD OF TREATMENT OF CANCER OR TUMOUR | ADAPTIMMUNE LIMITED (GB) | 2021-11-18 | — | — | WO | disclosed |
| WO-2021229212-A1 | MODIFIED IPSCS | ADAPTIMMUNE LIMITED (GB) | 2021-11-18 | — | — | WO | disclosed |
| CN-106148311-B | A kind of mutant of D-Psicose -3- epimerase and its application | 上海立足生物科技有限公司 | 2019-06-21 | — | — | CN | disclosed |
| CN-108392667-A | Desalination scar medical dressing with tissue inducing function and preparation method thereof | 苏州纳晶医药技术有限公司 | 2018-08-14 | — | — | CN | disclosed |
| CN-101906429-A | Serine-tryptophan protein kinase gene and preparation method and application thereof | UNIV WUHAN | 2010-12-08 | — | — | CN | disclosed |
| US-20100065493-A1 | MICROBIAL DEGRADATION OF WATER-BORNE PAINT CONTAINING HIGH LEVELS OF ORGANIC SOLVENT | ATOTECH DEUTSCHLAND GMBH & CO. KG (F/K/A ATOTECH DEUTSCHLAND GMBH) (DE) | 2010-03-18 | — | — | US | disclosed |
| EP-2111378-A2 | MICROBIAL DEGRADATION OF WATER-BORNE PAINT CONTAINING HIGH LEVELS OF ORGANIC SOLVENT | ATOTECH Deutschland GmbH (DE) | 2009-10-28 | — | — | EP | disclosed |
| US-20090023188-A1 | Heparin/heparosan synthase from P. multocida and methods of making and using same | NATIONAL SCIENCE FOUNDATION | 2009-01-22 | — | — | US | disclosed |
| WO-2008094872-A2 | MICROBIAL DEGRADATION OF WATER-BORNE PAINT CONTAINING HIGH LEVELS OF ORGANIC SOLVENT | ATOTECH DEUTSCHLAND GMBH (DE) | 2008-08-07 | — | — | WO | disclosed |
| US-20080185337-A1 | MICROBIAL DEGRADATION OF WATER-BORNE PAINT CONTAINING HIGH LEVELS OF ORGANIC SOLVENT | ATOTECH DEUTSCHLAND GMBH (DE) | 2008-08-07 | — | — | US | disclosed |
| CN-1976595-A | Preparation of canola protein isolate and use in aquaculture | BURCON NUTRASCIENCE (CA) | 2007-06-06 | — | — | CN | disclosed |
| US-6362275-B1 | MIXTURE CONTAINING AMINO ACID | ASHLAND INC. | 2002-03-26 | — | — | US | disclosed |
| EP-0498665-B1 | Hydroxamic acids derivatives, process for their preparation and use thereof | BRITISH BIOTECH PHARM (GB) | 1996-04-24 | — | — | EP | disclosed |
| US-4801529-A | INCUBATION, SEPARATION, DETECTION; ENZYMES, ANTIGENS, ANTIBODIES | BRANDEIS UNIVERSITY (US) | 1989-01-31 | — | — | US | disclosed |